Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
Clinical Data Inc (NASDAQ GM:CLDA)7/28/2010
most recent headlinesmore headlines:       
MONDAY, JUNE 14, 2010
11:54 AMClinical Data, Inc. Announces Closing of $32.0 Million Public Offering Including Full Exercise of Over-Allotment - BusinessWire
9:12 AMClinical Data, Inc. Reports Fourth Quarter and Fiscal Year 2010 Results - BusinessWire
WEDNESDAY, JUNE 09, 2010
8:31 AMClinical Data, Inc. Prices Public Offering of Common Stock - BusinessWire
TUESDAY, JUNE 08, 2010
4:05 PMClinical Data, Inc. Announces Public Offering of Common Stock - BusinessWire
THURSDAY, JUNE 03, 2010
7:15 AMClinical Data, Inc. Announces Data Confirming the Value of FCGR3A Gene Variant in Predicting Rituximab Response in Non-Hodgkin's Lymphoma to be Presented at ASCO - BusinessWire
TUESDAY, MAY 25, 2010
1:00 PMClinical Data, Inc. Announces Vilazodone Data Featured at the 2010 American Psychiatric Association and Society of Biological Psychiatry Annual Meetings - BusinessWire
MONDAY, MAY 24, 2010
6:49 AMClinical Data, Inc. Announces FDA Acceptance of New Drug Application for Vilazodone for the Treatment of Major Depressive Disorder - BusinessWire
WEDNESDAY, MAY 12, 2010
7:15 AMClinical Data, Inc. Expands FAMILION(R) Genetic Test Offerings and Delivers Scientific Presentations at Heart Rhythm Society Meeting - BusinessWire
TUESDAY, MAY 04, 2010
8:00 AMClinical Data, Inc. to Present at the JMP Securities Research Conference - BusinessWire
MONDAY, MAY 03, 2010
7:03 AMClinical Data, Inc. Licenses Adenosine A2A Agonist to Santen for Development of Ophthalmic Treatments - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.